Netcare Limited
Netcare Limited (NWKHY) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Netcare Limited (NWKHY), covering cash flow, earnings, and balance sheets.
Netcare Limited (NWKHY) Income Statement & Financial Overview
Explore comprehensive income reports for Netcare Limited NWKHY, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $13.17B | $12.03B | $12.16B | $6.08B |
| Cost of Revenue | $6.67B | $6.08B | $6.15B | $3.07B |
| Gross Profit | $6.50B | $5.96B | $6.01B | $3.007B |
| Gross Profit Ratio | $0.49 | $0.49 | $0.49 | $0.49 |
| R&D Expenses | $0.00 | $0.00 | $1.00M | $1.00M |
| SG&A Expenses | $5.25B | $4.66B | $4.73B | $2.39B |
| Operating Expenses | $3.34B | $4.71B | $4.73B | $2.35B |
| Total Costs & Expenses | $10.01B | $10.79B | $10.88B | $5.42B |
| Interest Income | $0.00 | $194.00M | $85.00M | $222.50M |
| Interest Expense | $0.00 | $1.16B | $529.00M | $0.00 |
| Depreciation & Amortization | $389.00M | $1.33B | $641.00M | $192.00M |
| EBITDA | $2.02B | $4.44B | $2.02B | $905.50M |
| EBITDA Ratio | $0.15 | $0.37 | $0.16 | $0.15 |
| Operating Income | $3.16B | $1.46B | $1.28B | $713.50M |
| Operating Income Ratio | $0.24 | $0.12 | $0.11 | $0.12 |
| Other Income/Expenses (Net) | -$2.008B | $486.00M | -$436.00M | -$277.00M |
| Income Before Tax | $1.15B | $1.95B | $848.00M | $436.50M |
| Income Before Tax Ratio | $0.09 | $0.16 | $0.07 | $0.07 |
| Income Tax Expense | $310.00M | $562.00M | $203.00M | $101.50M |
| Net Income | $822.00M | $646.00M | $673.00M | $319.50M |
| Net Income Ratio | $0.06 | $0.05 | $0.06 | $0.05 |
| EPS | $0.56 | $0.97 | $4.90 | $2.40 |
| Diluted EPS | $0.59 | $0.97 | $4.80 | $2.40 |
| Weighted Avg Shares Outstanding | $1.37B | $1.30B | $132.62M | $133.71M |
| Weighted Avg Shares Outstanding (Diluted) | $1.30B | $1.30B | $135.17M | $135.20M |
Financial performance has remained strong, with revenue growing from $6.08B in Q3 2023 to $13.17B in Q4 2024. Gross profit continued to perform well, with margins at 49% in the latest quarter. Operating income reached $3.16B in Q4 2024, holding a steady 24% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $2.02B. Net income rose to $822.00M, keeping EPS at $0.56. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan